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The neural network of the temporal lobe is thought to
provide a cognitive map of our surroundings. Func-
tional analysis of this network has been hampered
by coarse tools that often result in collateral damage
to other circuits. We developed a chemogenetic
system to temporally control electrical input into
the hippocampus. When entorhinal input to the per-
forant path was acutely silenced, hippocampal firing
patterns became destabilized and underwent exten-
sive remapping. We also found that spatial memory
acquired prior to neural silencing was impaired by
loss of input through the perforant path. Together,
our experiments show that manipulation of entorhi-
nal activity destabilizes spatial coding and disrupts
spatial memory. Moreover, we introduce a chemoge-
netic model for non-invasive neuronal silencing that
offers multiple advantages over existing strategies
in this setting.INTRODUCTION
During exploration of a novel environment, hippocampal neurons
become responsive to specific locations, collectively generating
a neural map for the new space. Their unique firing pattern offers
a theoretical memory code for a particular environment, as well
as a neural basis for recalling experiences associated with it. In
this hypothesis, the same set of hippocampal neurons activated
during initial exposure to a new space are used to support
navigation on subsequent encounters. Several features of hippo-
campal place cells argue in favor of this hypothesis. First, someThis is an open access article under the CC BY-Nhippocampal place fields are stable for weeks or months, sug-
gesting they encode long-termmemory of a learned environment
(Ziv et al., 2013). Second, place fields established during maze
learning are sequentially reactivated before re-entering the
maze, suggesting a reference map for successful navigation
(Pfeiffer and Foster, 2013). Third, blocking consolidation of hip-
pocampal firing sequences with NMDAR inhibitors impairs recall
of goal-directed navigation, suggesting these unique firing pat-
terns are essential for retrieval (Dupret et al., 2010).
Despite the appeal of a link between place field reactivation
and spatial memory, experimental proof has been limited by
the approaches available to dissect this complex circuit. Electro-
lytic and pharmacological lesions to inactivate cortical projec-
tions to the hippocampus impact spatial properties of CA1 neu-
rons (Miller and Best, 1980; Brun et al., 2008; Van Cauter et al.,
2008; Hales et al., 2014; Miao et al., 2015; Ormond and
McNaughton, 2015; Schlesiger et al., 2015) and impair spatial
learning (Good and Honey, 1997; Remondes and Schuman,
2004; Van Cauter et al., 2013; Hales et al., 2014). However, these
lesioning methods have particular drawbacks in the entorhinal
cortex where neurons in neighboring layers can have discrete
targets and serve distinct functions. Such topographical preci-
sion requires genetic approaches capable of providing regional,
layer, or cell-type specificity. Ideally, studies to functionally
dissect the hippocampal-entorhinal network would harness
both the topographic specificity of genetic approaches and the
temporal precision of light- or ligand-activated channels. Here,
we describe a transgenic system for neuronal silencing that
meets these dual objectives. Our approach is based on a modi-
fied human glycine receptor (GlyCl) that is activated using the
peripherally delivered ligand ivermectin (Lynagh and Lynch,
2010). The concept of this system is similar to other engineered
receptors for neuronal silencing (i.e., PSAMor DREADDs) (Stern-
son and Roth, 2014), but uses an inexpensive and widelyCell Reports 16, 793–804, July 19, 2016 ª 2016 The Author(s). 793
C-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
Figure 1. The GlyCl Transgene Vector and Its Expression in the Nop-tTA Model
(A) Viral T2a peptides separate a YFP tag from flanking copies of the modified glycine receptor a subunit, all under control of the tet-responsive TRE3G promoter.
The stability of mature processedmRNAwas enhanced by incorporation of the first intron from themouse prion protein gene at the 50 end and by theWPRE at the
30 end of the transcript.
(B) Two zones of intense YFP fluorescence are apparent in horizontal brain sections from aNop-GlyCl mouse: the entorhinal area (shown here) and the cerebellum
(shown in Figure S1).
(C) Strong YFP expression is seen in the superficial layers of entorhinal cortex, the neighboring pre- and para-subiculum, and the terminal field of the perforant
path in the molecular layer of the dentate gyrus (arrow).
(D) Immunostaining for GlyCl in the section from (C) demonstrates that GlyCl expression is found within the soma of entorhinal and subicular neurons, but is
absent from the perforant path (arrow).
(E–G) High-magnification images within the entorhinal cortex show the correspondence between YFP expression (E) and GlyCl immunostaining (F) in a merged
image (G) from Nop-GlyCl tissue.
See also Figures S1 and S2 and Table S1.available drug for activation. By placing GlyCl expression under
control of the tetracycline-transactivator (tTA), we can flexibly
target neuronal populations by interbreeding with existing tTA
driver lines. Here, we use one such tTA line to express GlyCl
within the superficial entorhinal cortex.We show that the chemo-
genetic suppression of neural activity in this model elicits dra-
matic remapping of hippocampal place fields and impairs recall
of a trained location in a familiar environment. We thus introduce
a model system for non-invasive dissection of circuit function
that supports an operational correlation between spatial memory
and hippocampal place field stability.
RESULTS
Transgenic Expression of an Engineered Chloride
Channel for Reversible Suppression of Neuronal Firing
Wesought to develop a chemogenetic approach for non-invasive
neuronal silencing based on the human glycine-gated chloride
channel (GlyCl). This homopentameric receptor had been opti-794 Cell Reports 16, 793–804, July 19, 2016mized by Lynagh and Lynch (2010) for ligand-controlled neural
silencing using inexpensive and readily available anti-parasitic
avermectin drugs to activate a hyperpolarizing chloride current
in mature neurons. Substitution at F207A reduced sensitivity for
glycine, while a second substitution at A288G increased sensi-
tivity for ivermectin (IVM). We used this F207A/A288G cDNA to
create a transgenic construct in which two copies of themodified
GlyCl channel and aYFP fluorescent indicatorwere placed under
control of the tet-responsive promoter TRE3G (Figure 1A).
Placing GlyCl in the Entorhinal Cortex
The perforant pathway is the archetypal conduit for cortical infor-
mation into the hippocampus, making it an obvious target for
probing the link between successful recall of navigational mem-
ory and the stability of spatial tuning by hippocampal neurons.
We crossed our TRE-GlyCl transgenic responder line to the
EC-tTA driver line based on the neuropsin promoter (also known
as Nop-tTA) (Yasuda and Mayford, 2006) to generate bigenic
offspring expressing the IVM-sensitive GlyCl channel within the
Figure 2. Neuronal Silencing with Iver-
mectin in Acute Brain Slice Preparations
(A) Example voltage traces from whole-cell re-
cordings in control (top row) and Nop-GlyCl mice
(bottom row). GlyCl-expressing neurons initiate
action potentials in response to stepped current
injection when perfused with ACSF (black) but fail
to respond in the presence of 100 nM IVM (red).
(B) Application of IVM hyperpolarized the resting
membrane potential of GlyCl-expressing neurons.
(C) In the presence of 100 nM IVM, GlyCl ex-
pressing neurons fail to elicit action potentials
except at supra-threshold current intensities.
Control, n = 7 cells from four animals; Nop-GlyCl,
n = 5 cells from five animals.
(D) The excitatory post-synaptic response evoked
by perforant path stimulation is reduced by IVM
application in Nop-GlyCl brain slices. Insets show
representative traces recorded at a stimulation
intensity of 200 mA in the presence (red) or absence
(black) of IVM. Control, n = 15 slices from six ani-
mals; Nop-GlyCl, n = 11 slices from six animals.
See also Table S2.entorhinal cortex (hereafter abbreviated Nop-GlyCl). Although
the Nop-tTA line is not specific for the entorhinal cortex (Yetman
et al., 2016), the highest density of cells with strong YFP signal
was found in the superficial medial entorhinal cortex and neigh-
boring pre- and parasubiculum (Figure 1B). Axonal terminals
of the perforant path were clearly visible by YFP labeling within
the molecular layer of the dentate gyrus (Figure 1C), confirming
the layer 2 localization of transgene expression within entorhinal
cortex. Although transgene expression was strongest in layer 2,
YFP labeling was not found in all layer 2 neurons, nor was trans-
gene expression fully excluded from other layers within this re-
gion. Immunostaining for GlyCl confirmed fidelity of the YFP label
at the soma, with intense GlyCl immunostaining at the cell mem-
brane and YFP more diffusely distributed throughout the cyto-
plasm (Figures 1D–1G). As expected from previous studies withCthis driver line (Yetman et al., 2016), mod-
erate transgene expression was also seen
in the deep layers of parietal association
area, anterior cingulate cortex, and retro-
splenial cortex, with sparse scattered
YFP+ cells across many other regions of
the forebrain (Figure S1). Unexpectedly,
cerebellar YFPexpression appeared inde-
pendent of tTA in single transgenic TRE-
GlyCl mice and the bigenic Nop-GlyCl
animals (Figure S1). A similar pattern of
tTA-independent YFP labeling was seen
in several other TRE-GlyCl founder lines
created from the same construct (Fig-
ure S2; Table S1). This site of ectopic
expression was notable because past
studies have shown that chronic sup-
pression of cerebellar LTD impairs spatial
navigation basedon self-motion cues (Ro-
chefort et al., 2011; Lefort et al., 2015).With this in mind, we included GlyCl single transgenic animals
as controls for all work with Nop-GlyCl mice to account for any
cerebellar phenotypes that might influence our findings.
Neuronal Silencing with IVM In Vitro and In Vivo
We next confirmed that entorhinal GlyCl expression would
render these neurons susceptible to IVM. We prepared acute
brain slices for electrophysiology from 6- to 8-week-old Nop-
GlyCl mice and single- or non-transgenic (NTG) control siblings.
Pyramidal neurons in the entorhinal cortex (EC) were identified
by fluorescence in Nop-GlyCl animals and by relative size and
location in control animals. The frequency of action potentials
evoked by stepped current injections in standard artificial cere-
brospinal fluid (ACSF) showed no difference between control
and Nop-GlyCl cells (Figures 2A–2C; Table S2; three-wayell Reports 16, 793–804, July 19, 2016 795
Figure 3. In Vivo Pharmacokinetics and Pharmacodynamics of Ivermectin Silencing
(A and B) Liquid chromatography-tandem mass spectrometry (LC-MS/MS) was used to measure free drug concentration in plasma (A) and brain (A and B) from
wild-type mice collected 3 hr to 4 days after a single IVM injection. n = 4 mice per time point (two M, two F). Dotted line indicates T1/2 = 13.3 hr.
(C) The pharmacodynamics of IVM at the GlyCl channel was assessed by multi-tetrode recording during open field exploration in CaMKIIa-GlyCl animals. Raster
plots show five simultaneous multi-unit recordings (1 trace per tetrode, 2 s of data) taken before, 2 hr, and 4 hr after injection of vehicle (upper row) or IVM
(lower row).
(D) Each row of the raster plots shows the action potentials fired by one neuron during sequential laps on the linear track (blue) and average firing rate versus
position (red) recorded before, 2 hr, and 4 hr after injection of vehicle (upper row) or IVM (lower row) in CaMKIIa-GlyCl mice. See also Figure S3.
(E and F) Both single- andmulti-unit activity in open field remained stable for 4 hr after vehicle injection, but both were significantly reduced by 4 hr after IVM. Data
recorded after IVM injection are shown in red. Graphs show median ± interquartile range, each point represents the firing rate at one tetrode (E), or of a single
putative pyramidal neuron (F). n = 3 mice.
See also Figure S3 and Table S2.ANOVA, main effect of genotype, p < 0.0001; post hoc Nop-
GlyCl ACSF versus Control ACSF, p = 0.2424). Subsequent
application of 100 nM IVM significantly reduced the resting
membrane potential (unpaired t test, p < 0.001) and substantially
impaired spike initiation only in GlyCl-expressing cells (three-
way ANOVA, post hoc Nop-GlyCl ACSF versus Nop-GlyCl
IVM, p < 0.0001). Supra-threshold stimulation elicited no action
potentials in GlyCl-expressing neurons until 140 pA, and any
spiking that did occur at higher intensities (180–200 pA) was at
a greatly reduced rate compared to controls.
We next examined the impact of IVM-mediated silencing on
synaptic transmission of entorhinal neurons through the perfo-
rant path. These recordings measured the slope of field excit-
atory postsynaptic potential (EPSPs) in the molecular layer of
dentate gyrus following stimulation of the perforant path. In con-
trol animals, the stimulus-response relationship was unaffected
by application of 100 nM IVM (Figure 2D; three-way ANOVA, ge-
notype 3 treatment interaction, p < 0.0001; post hoc Control
ACSF versus Control IVM, p = 0.3360). In contrast, IVM signifi-
cantly depressed the stimulus-response curve in field recordings
fromNop-GlyCl animals (three-way ANOVA, post hoc Nop-GlyCl
ACSF versus Nop-GlyCl IVM, p < 0.0001). The magnitude of this796 Cell Reports 16, 793–804, July 19, 2016change, 43% ± 0.06% at plateau intensities between 300–
400 mA, corresponded well with previous studies in which Nop-
tTA was used to express tetanus toxin in this region and with
the same authors’ estimate that 43% of superficial entorhinal
neurons express tTA in this driver line (Yasuda et al., 2011)
IVM can be systemically administered by multiple routes, but
brain concentration is limited by active efflux of the p-glycopro-
tein transporter (Geyer et al., 2009; Kiki-Mvouaka et al., 2010).
We therefore examined the pharmacokinetics of IVM distribution
in wild-type mice following a single intraperitoneal injection of
5 mg/kg. IVM concentration in the brain was near maximal by
3 hr post injection, peaked at 9 hr, then declined sharply with a
T1/2 of 13.3 hr (Figures 3A and 3B). The maximum brain concen-
tration reached 65 ng IVM per gram brain weight, or 74 nM,
approximately the concentration at which our whole-cell record-
ings in acute brain slices showed nearly complete inhibition of
action potential initiation. We therefore administered IVM at
5 mg/kg intraperitoneal for all subsequent in vivo experiments.
We next used multi-tetrode recordings in awake behaving
mice to examine the pharmacodynamics of IVM on neural activ-
ity in the brain following a single injection of IVM. For this exper-
iment, we expressed GlyCl within hippocampal neurons using
the CaMKIIa-tTA driver line to assess the direct effect of IVM-
induced silencing on CA1 neurons. CA1 activity was continu-
ously recorded for5 hr each day, allowing us to compare neural
activity before and after IVM administration. On each day of
recording, animals underwent three behavior sessions during
which they ran laps on a linear track and then explored freely
in open field, before they were returned to the home cage for
2 hr rest. On the first day, animals were injected with vehicle
immediately after the baseline session and were returned to
the track and open field for testing at 2 and 4 hr after injection.
On the second day, IVM was substituted for vehicle in an other-
wise identical protocol.
Multi-unit recordings revealed that the median firing rate in
CaMKIIa-GlyCl mice did not change following vehicle injection,
but decreased markedly within 2 hr of IVM treatment and
declined still further by 4 hr, consistent with the pharmacoki-
netics of IVM in wild-type mice (Figures 3C and 3E; Kruskal-
Wallis, p = 0.0177; post hoc baseline versus IVM 4 hr, p =
0.0022). The same temporal pattern was apparent in the single
unit activity of many CA1 neurons (Figures 3D and 3F; Kruskal-
Wallis, p < 0.0001; post hoc baseline versus IVM 2 hr, p =
0.0004; baseline versus IVM 4 hr, p < 0.0001). We further
analyzed the single unit data using rate curves (Figure 3D, red
traces) as a graphical depiction of the relationship between an
animal’s position on the linear track and the average firing rate
of the cell. For each place cell identified, we computed be-
tween-session stability as a measure of how similar the firing
rate curve was in the baseline session to those following treat-
ment. Similar computations were done to assess between-
session stability of two-dimensional rate maps in open field
recordings. Compared with vehicle treatment the day before,
direct silencing of CA1 neurons in the CaMKIIa-GlyCl mice
sharply reduced the between-session stability both in open field
exploration and on the linear track (Figure S3; Kruskal-Wallis, p <
0.0001; open field post hoc Vehicle versus IVM, p < 0.0001; linear
track post hoc Vehicle versus IVM, p < 0.0001).
Pharmacogenetic Silencing of Superficial EC Disrupts
Spatial Tuning in CA1
Returning to the Nop-GlyCl mice, we expected IVM administra-
tion to diminish the amplitude and disrupt the patterning of trans-
mission through the perforant path and predicted that this
change might influence the spatial tuning of downstream CA1
neurons. Because IVM administration had an equivalent effect
on place field stability in CaMKII-GlyCl mice regardless of
whether we recorded on a one-dimensional linear track or a
two-dimensional open field (Figure S3), we opted to use the
more reliable linear track measures for all subsequent analyses.
Further, animals show a clear improvement in track performance
with continued days of training, suggesting that track running for
food reward is a learned behavior (Figure S4; two-way repeated
measure (RM) ANOVA, main effect of day, p < 0.0001; post hoc
day 1, 2 versus day 6, 7, p < 0.0001 for all comparisons, all ge-
notypes). We tested three groups of mice in this experiment:
Nop-GlyCl bigenic animals, GlyCl single transgenic animals,
and a control group comprised of both NTG and tTA single trans-
genic animals. Similar to the previous protocol, CA1 activity was
continuously recorded throughout the 5 hr experiment andcompared between three track running sessions: baseline,
2 hr, and 4 hr after systemic administration of either vehicle or
IVM. Between-session stability approached 0.6 for all three
groups and was unchanged by IVM injection in the control and
GlyCl single transgenic groups (Figure 4A). However, IVM treat-
ment in the Nop-GlyCl mice precipitated a dramatic decline in
the between-session stability (Figures 4A and S5; Kruskal-
Wallis, p < 0.0001; post hoc vehicle versus IVM, p < 0.0001).
The relative order, peak rate, and firing position for each cell
remained relatively consistent between baseline and 4 hr after
vehicle injection (Figure 4B), but were severely disrupted by
IVM in the Nop-GlyCl mice (Figure 4C). Compared to the highly
consistent location of place fields observed in control mice after
either vehicle or IVM injection (Figures 4D and 4E), place fields in
Nop-GlyCl mice remained stable and well-defined after vehicle
injection (Figure 4F) but often appeared more diffuse or became
active in new locations following IVM injection (Figure 4G). In
some cases, cells that were active during baseline became silent
after IVM, and in others, cells that were silent developed well-
defined place fields.
We next examined what factors contributed to the decline in
rate map correlation following IVM administration in the Nop-
GlyCl model. We began by comparing spatial information (SI) be-
tween sessions, which offers a measure of how unambiguously
the firing of each place cell reflects the position of the animal.
The SI provided byCA1 neuronswas unchangedby IVM injection
in control and GlyCl groups, but was significantly reduced in
Nop-GlyCl mice (Figure 5A; Tables S2 and S3; Kruskal-Wallis,
p < 0.0001; post hoc baseline versus IVM 2 hr, p = 0.0003;
baseline versus IVM 4 hr, p = 0.0016). In concert with this change
in SI, the average length represented by each place field
increased significantly in the IVM-treated Nop-GlyCl mice (Fig-
ure 5B; two-way ANOVA, genotype 3 treatment interaction,
p < 0.0001; post hoc baseline versus IVM 2 hr and versus IVM
4 hr, p < 0.0001). These changes occurred without any decline
in overall firing rate: both multi-unit and aggregate single unit
activity were stable across days and between sessions for all
genotypes (Figures S6A and S6B). Moreover, the average and
peak firing rates of putative pyramidal neurons were unchanged
(Figures S6D and S6E). In contrast to past studies of entorhinal
lesions (Bragin et al., 1995; Schlesiger et al., 2015), we found
no change in theta power between sessions on either day of
testing (Figures S6C and S6G). This discrepancy is likely due to
the limited targeting of layer 2 neurons with the Nop-tTA driver
(40%–50%) compared with the near-total cell loss produced
by physical lesions in the earlier studies. Similarly, although
past studies have shown a relationship between run speed and
CA1 theta power (Long et al., 2015), the slowing of Nop-GlyCl
mice after IVM may have been too small to significantly impact
theta amplitude here (Figure S6F). IVM silencing had no impact
on the proportion of cells with place fields nor in the number of
place fields per cell (Table S4). The increase in field size clearly
contributed to the drop in SI, but analysis of rate curves from
Nop-GlyCl mice before and after IVM indicate that positional sta-
bility was also a factor.
To better understand the nature of place field instability
caused by IVM silencing, we categorized cells as remaining sta-
ble if neither peak firing rate nor position changed betweenCell Reports 16, 793–804, July 19, 2016 797
Figure 4. IVM Silencing Causes Place Field Instability in Nop-GlyCl Mice
(A) Between-session stability was measured by the correlation of rate curves computed at baseline with those attained 2 and 4 hr after vehicle (gray) or IVM (red).
IVM significantly decreased between-session correlation only for Nop-GlyCl mice. Graph shows median ± interquartile range. n = 4 mice/genotype.
(B and C) Example rate maps from five cells simultaneously recorded in a Nop-GlyCl mouse at baseline each day and again 2 hr and 4 hr after injection of vehicle
(B) or IVM (C).
(D–G) Examples of raw data from individual neurons of control (D and E) and Nop-GlyCl mice (F andG) during baseline recording and at 2 hr and 4 hr after injection
of vehicle (D and F) or IVM (E and G). Lap-by-lap raster plot of single neuron firing is shown in blue; average firing rate versus linear track position is shown in red.
See also Figures S4 and S5 and Table S2.sessions; as undergoing rate modulation if firing rate, but not
place field location, differed; or as undergoing global remapping
if place field location was altered (Figure 6A). The fraction of cells
in each category was similar between genotypes after vehicle
administration (Figure 6B; three-way ANOVA, genotype 3 treat-
ment 3 classification, p = 0.00496). In IVM-treated Nop-GlyCl
mice, however, stable place cells decreased by more than
two-thirds (post hoc vehicle versus IVM, p = 0.1123) while the
number of cells that underwent global remapping increased
3-fold (post hoc vehicle versus IVM, p = 0.0251). These experi-
ments prove that disruption of entorhinal input to the hippocam-
pus—either on its own or in addition to the disruption of activity in
several other areas where GlyCl was expressed—significantly
destabilizes spatial tuning of CA1 pyramidal neurons.
Navigation in a Familiar Environment Is Impaired
following Disruption of Entorhinal Input to Hippocampus
Having established a model in which we could experimentally
induce global remapping of CA1 place fields, we next tested
whether the same manipulation of entorhinal activity would
impact spatial navigation. We observed no differences in loco-
motion or anxiety between genotypes in open field or straight
swim training (Figure S7) and so proceeded with Morris water798 Cell Reports 16, 793–804, July 19, 2016maze (MWM) training. The MWM task allowed us to overcome
the unanticipated scratching behavior caused by IVM in the
Nop-GlyCl mice. This behavior was never observed in control
animals and was most apparent during place cell recording as
animals paused at each end of the track for food reward. This
period of inactivity is excluded from analysis for all animals and
thus did not affect place cell measurements. Because mice
cannot scratch and swim at the same time, the use of MWM
eliminated this confound from our behavioral testing.
We previously validated a modified version of the MWM in
which learning is assessed at the end of each day using a
short-term memory probe, and training continues for each
mouse until it reaches pre-fixed success criteria (Fowler et al.,
2014). Using this protocol, all four genotypes learned the location
of the hidden platform in thewater maze, although the Nop-GlyCl
group took more training to master the task than GlyCl single
transgenic animals (Figure 7A; Kruskal-Wallis, p = 0.0211; post
hoc GlyCl versus Nop-GlyCl, p = 0.0319) and swam significantly
farther during the initial days of training than controls (Figure 7B;
two-way RM ANOVA, main effect of genotype, p = 0.0415, all
post hoc comparisons n.s.). This delay in acquisition may have
resulted from GlyCl expression during postnatal development
of the perforant pathway and suggests that future studies may
Figure 5. Decreased Specificity of Spatial Tuning following Entorhinal Silencing in Nop-GlyCl Mice
(A) Spatial information was calculated for active cells during each session and remained stable for all genotypes following vehicle injection, but was significantly
reduced by IVM in the Nop-GlyCl mice. Data obtained after IVM injection are shown in red. Graph shows median ± interquartile range.
(B) Field length was stable across all sessions in control and GlyCl mice, but increased significantly after IVM administration in Nop-GlyCl animals. Graph shows
mean ± SEM. n = 4 mice/genotype.
See also Figure S6 and Tables S2, S3, and S4.benefit from rearing animals on doxycycline to withhold trans-
gene expression until adulthood. After reaching criteria, animals
were retired from further training until the lastmousehadfinished,
and the next day all animals underwent a single day of refresher
training to ensure equivalent performance across groups prior
to long-term memory assessment. Although the Nop-GlyCl
mice had taken more days to learn the task, they performed as
well as controls during refresher training (one-way ANOVA,
path length p = 0.5710) and during the probe trial immediately
following refresher training (one-way ANOVA, % path in trained
quadrant p = 0.9376; proximity to phantom platform, p = 0.3392).
After confirming that all mice had learned the task equally well,
we then tested whether long-term spatial memory was disrupted
concurrent with CA1 remapping. The day after refresher training,
mice were injected with vehicle solution and 3 hr later underwent
a single probe trial to assess spatial recall. As expected from the
design of this task, all four genotypes performed equally well
following vehicle injection, displaying equivalent proximity to
the phantom platform (Figure 7E; two-way RM ANOVA, treat-
ment 3 genotype interaction, p < 0.0001, all post hoc genotype
comparisons after vehicle injection were n.s. [in contrast to the
IVM response described below]). Examples of the swim paths
taken by mice from each genotype during this post-vehicle
probe test clearly favor the trained northeast quadrant of the
pool (Figure 7C; Movie S1) and average percent of swim path
within the target quadrant was similar for all four genotypes
(40%–45%; Figure 7D; two-way RM ANOVA, treatment3 geno-
type interaction p = 0.0073, all post hoc genotype comparisons
after vehicle injection were n.s [again, in contrast to IVM
response described below]). Thus by all measures, spatial recall
in the Nop-GlyCl group was equivalent to the control groups
under vehicle conditions.
We next tested the impact of IVM silencing on spatial recall in
this now-familiar environment. All mice first received one final
training session to prevent memory extinction by prior probe
testing. The following day, animals were injected with IVM and3 hr later underwent a second probe test for long-term spatial
memory. In contrast to IVM-treated control animals, the swim
paths of IVM-treated Nop-GlyCl mice showed little or no prefer-
ence for the trained quadrant (Figure 7C). Following IVM admin-
istration, Nop-GlyCl animals occupied the trained quadrant
significantly less and focused their search for the phantom plat-
form with significantly lower precision than they had following
vehicle injection (two-way RM ANOVA for % path, treatment 3
genotype interaction, p = 0.0073, post hoc Nop-GlyCl vehicle
versus IVM p = 0.0061; two-way RM ANOVA for proximity, treat-
ment 3 genotype interaction, p < 0.0001, post hoc Nop-GlyCl
vehicle versus IVM p < 0.0001). To rule out the possibility that
the navigational effect of neuronal silencing was caused by
non-specific impairments in visual acuity or swimming ability,
we performed a visible cue variation of the water maze immedi-
ately after completing the IVM probe trial. Because the average
path length swum by Nop-GlyCl mice in the visible platform trials
was longer than other IVM-treated groups (Figure S7G; one-way
ANOVA, p = 0.0237, all post hoc comparisons were n.s.), we
looked more carefully at the individual trial data. This analysis re-
vealed a main effect of genotype for path length, but none of the
post hoc comparisons were significant for any quadrant tested
(Figure S7I; two-way RM ANOVA, main effect of genotype, p =
0.0214). We conclude from these analyses that the IVM-treated
Nop-GlyCl mice were capable of swimming to a well-defined
target as efficiently as controls, however, they appeared to do
so less consistently than controls. This may reflect inflexibility
for changing task demands rather than visual or attentional
impairment. Collectively these findings suggest that spatial recall
relies on continued entorhinal input, stable CA1 positional tun-
ing, or both, even within a familiar environment.
DISCUSSION
Despite remarkable progress in analyzing circuits that support
spatial tuning in the hippocampus, methods for experimentallyCell Reports 16, 793–804, July 19, 2016 799
Figure 6. Neuronal Silencing in Nop-GlyCl Mice Induces Global Remapping of CA1 Place Fields
(A) Example cells that underwent global remapping, rate modulation, or remained stable are shown as lap-by-lap spike rasters in blue and average firing rate
versus linear position in red.
(B) Firing rate curves at baseline were compared with those obtained for the same cell 2 hr and 4 hr after vehicle or IVM injection. The fraction of place fields that
underwent global remapping (red), rate modulation (green), or remained stable (blue) was unchanged between vehicle and IVM for control and GlyCl mice, but
was significantly shifted toward increased global remapping at the expense of stable fields in Nop-GlyCl mice after IVM injection. n = 4 mice/genotype.
See also Table S2.manipulating elements of this system have been comparatively
limited. Here, we introduce a transgenic model that allows
spatial control over neuronal activity in navigational circuits in a
behaviorally relevant time frame. The GlyCl-ivermectin approach
described here has several advantages over existing systems
such as optogenetics, DREADDs, and PSAMs for neuro-func-
tional studies (Sternson and Roth, 2014). The GlyCl channel
is activated by a systemically delivered ligand amenable to use
in widely dispersed neural populations or regions difficult to
implant with fiber optics and does not require intracellular sec-
ond messengers for its function. Ivermectin is widely available
and well-characterized. Activation of endogenous mammalian
receptors can occur at high doses (Wolstenholme, 2010; Zem-
kova et al., 2014), but with more than a dozen avermectin and
milbemycin variants available, alternative ligands may emerge
to improve brain penetrance and minimize off-target modulation
(Shoop et al., 1995; Prichard et al., 2012).
Our work builds on a longstanding quest to define the relation-
ship between hippocampal place fields and spatial memory.
Previous studies showed that the dynamic realignment between
environmental landmarks and CA1 tuning was critical for suc-
cessful navigation and that animals were more likely to make
navigational errors during when changes in external cues caused
place fields to shift between training and testing (O’Keefe and
Speakman, 1987; Lenck-Santini et al., 2001). Subsequent
studies revealed that spatial learning deficits characteristic of
aging rodents were associated with diminished place field
stability in familiar locations and ineffective remapping in novel
environments (Barnes et al., 1997; Tanila et al., 1997; Oler and
Markus, 2000; Wilson et al., 2003). Consistent with the idea
that place fields are essential to encoding spatially anchored in-800 Cell Reports 16, 793–804, July 19, 2016formation, recent work has shown that events encountered
within a place field (such as food reward or foot shock) can cause
place field remapping and that tuning patterns generated during
acquisition become reactivated during recall of the rewarded
trajectory (Anderson and Jeffery, 2003; Moita et al., 2003,
2004; Smith and Mizumori, 2006; Dupret et al., 2010). Our
work builds on this foundation by showing that a single experi-
mental manipulation can both destabilize spatial tuning in CA1
and impair recall of established spatial memory. Because we
used entorhinal silencing to evoke CA1 instability, our current
model cannot disambiguate the contribution of CA1 instability
and entorhinal inactivation to spatial memory impairments.
The extensive bidirectional connections between entorhinal cor-
tex and hippocampus may ultimately prevent the two regions
from being separated experimentally in a meaningful way.
This consideration applies broadly to any experimental system
designed to ‘‘selectively manipulate’’ neurons within a highly
interconnected network, but is especially pertinent within the
temporal lobe. Despite these caveats of circuit manipulation,
our findings support an experimental correlation between
entorhinal output, hippocampal place field stability, and reliable
navigation of a known context.
Fundamental to our study was the discovery that neuronal
silencing in the Nop-GlyCl mice induced extensive remapping
of CA1 place fields. Past studies had shown that physical or
chemical lesions of the entorhinal cortex diminished the stability
of CA1 place fields, increased field size, and reduced the density
of spatial information provided by each cell (Miller and Best,
1980; Van Cauter et al., 2008; Hales et al., 2014; Schlesiger
et al., 2015). Here, we confirm these effects and further
demonstrate through continuous recordings that extensive
Figure 7. Neuronal Silencing in Nop-GlyCl Mice Impairs Spatial Recall in the Morris Water Maze
(A) A train-to-criteria version of theMorris watermazewas used to bring all animals to the same level of performance prior to testing long-termmemory. Nop-GlyCl
mice took more days of training to master the task than GlyCl single transgenic animals, but ultimately reached the same performance outcomes.
(B) Nop-GlyCl mice traveled longer distances to find the hidden platform during the first two days of training, however, once they reached criteria performance
they located the platform with the same efficiency as other genotypes during refresher training.
(C) Track plots show example swim paths taken by each genotype during vehicle (gray) and IVM (red) probe tests. Numbers in italic indicate the%of path spent in
the target quadrant for that trial.
(D) Percent of swim path spent in the target quadrant during long-termmemory probe tests following vehicle (gray) or IVM (red). Nop-GlyCl was the only genotype
for which quadrant occupancy decreased upon IVM administration.
(E) Nop-GlyCl mice swam significantly farther from the trained location after entorhinal silencing than they had following vehicle treatment the previous day. n =
4–11 mice/genotype.
See also Figure S7, Table S2, and Movie S1.CA1 remapping occurs in real time following entorhinal silencing.
This outcome adds to several recent reports in models of opto-
genetic, chemogenetic (DREADD), or pharmacologic (muscimol)
inactivation of MEC, where both CA1 and CA3 place fields were
found to undergo extensive destabilization and expansion within
tens of minutes following onset (Miao et al., 2015; Ormond and
McNaughton, 2015; Rueckemann et al., 2016). In contrast to
these models where stereotaxic injection of drug or virus biased
MEC inactivation toward dorsal or ventral populations but
spanned all cortical layers, we show that genetically isolating
MEC layer 2 had the same effect. Surprisingly, while these
studies of direct MEC inactivation support a strong influence
on hippocampal spatial tuning, more subtle manipulations to
specifically dampen entorhinal grid firing have reported little
impact on the positional stability of CA1 place fields (Koenig
et al., 2011; Brandon et al., 2014). This difference may simply
reflect the likelihood that CA1 place fields are shaped by many
types of feature-, positional-, proprioceptive-, and vestibular-
responsive cells in the entorhinal area and may be robust to
the specific loss of grid cell input.
It is also important to note that the Nop-tTA driver also induces
transgene expression in superficial layers of retrosplenial cortex,a region that contains head direction cells which contribute to
positional tuning of CA1 neurons and to spatial navigation. How-
ever, past work shows that while acute silencing of retrosplenial
cortex destabilizes hippocampal place fields and diminishes
initial search precision during probe trials, loss of retrosplenial
input was not sufficient to impair spatial navigation as long as
environmental cues were visible (Cooper and Mizumori, 1999,
2001; Czajkowski et al., 2014). Therefore, loss of retrosplenial
function is unlikely to cause the dramatic spatial memory impair-
ment evoked by ivermectin in the Nop-GlyCl mice, but this
warrants confirmation through future studies in which GlyCl
expression is strictly limited to the entorhinal cortex.
Another complication of the current model is the unexplained
scratching elicited by ivermectin administration in Nop-GlyCl
mice. The effect was selective to bigenic animals, occurred in
multiple TRE-GlyCl founder lines crossed to the Nop driver
(data not shown) and persisted even when the GlyCl transgene
was introduced specifically to the CNS by viral expression
(data not shown). Scratching abated over several days, which
is somewhat longer than the pharmacokinetics of ivermectin
clearance, but not inconsistent with drug perdurance in lipid
membranes. We tested spatial recall in the water maze becauseCell Reports 16, 793–804, July 19, 2016 801
swimming prevented the mice from scratching during the task.
Nevertheless, the feeling of itch could have distracted attention
from the task, leading to a drop in place field stability (Kentros
et al., 2004; Muzzio et al., 2009). However, ivermectin treatment
affected multiple field parameters not yet linked to attention,
including firing rate, field size, and spatial information, suggest-
ing that diminished attention was not likely responsible for the
extensive remapping we observed.
Admittedly, the linear track task used for place field analysis
may have had different attentional demands than the water
maze used to assess behavioral consequences of neuronal
silencing. Both track running in return for food reward and water
maze navigation are learned tasks, suggesting that both require
some degree of attention to master. However, once the shape
and setting of the track become familiar, successful navigation
may become more automatic than for the water maze where
variable start points and directional freedom require active
engagement with visible cues for guidance. Thus, it is possible
that the extent of remapping observed on a linear track may be
greater than in thewatermaze. However, even if the higher atten-
tional requirements of water maze testing lessened the impact
on place field size, stability, spatial information, and firing rate,
the changes that did occur were sufficient to cut spatial memory
performance down to chance levels.
Recognizing these caveats, our study nevertheless demon-
strates that the same acute disruption of entorhinal activity
was sufficient to both destabilize spatial tuning of CA1 place
fields and impair recall of established spatial memory. We are
optimistic that genetic tools such as the GlyCl channel described
here will transform how spatial navigation circuits are investi-
gated and will soon move the field from correlation to a causal
link between hippocampal activity sequences and subsequent
recall of places from which they arose.EXPERIMENTAL PROCEDURES
For detailed description, see the Supplemental Experimental Procedures.
Mice
TRE-GlyCl
The GlyCl coding cassette was engineered to contain the fluorescent reporter
from pEYFP-N1 (Clontech), flanked on either side by human GlyCla harboring
the F207A/A288G point mutations (Lynagh and Lynch, 2010), separated by
T2A peptide sequences (Trichas et al., 2008), and followed by a woodchuck
hepatitis post transcriptional regulatory element (WPRE) (Lerchner et al.,
2007). This cassette was ligated into the moPrp-TRE3G vector (modified from
Jankowsky et al., 2005) to build moPrp-TRE3G-GlyCla-2A-YFP-2A-Gly-
Cla-WPRE (abbreviated hereafter as TRE-GlyCl; Figure 1A). Mice harboring
the TRE-GlyCl construct were generated using standard techniques for pronu-
clear injectionandscreened for transgeneexpressionusingYFPexpressionand
IVMsensitivity. TRE-GlyCl line 9542wasbackcrossed to FVB/NJ for aminimum
of three generations before being mated with tTA driver lines described below.
Line 9542 is available from the Jackson Laboratory as stock #29302; additional
lines generated from the same construct are also available and described in
Supplemental Information. Both male and female TRE-GlyCl mice were used
for breeding, yielding offspring on a mixed hybrid background derived from
C3H,C57, andFVBstrains.All animal experimentswere reviewedandapproved
by the Baylor College of Medicine International Care and Use Committee.
Neuropsin-tTA
Mice expressing a humanized tTA under control of themouse neuropsin (Nop)/
protease serine 19 (Prss19)/Kallikrein-related peptidase 8 (Klk8) promoter802 Cell Reports 16, 793–804, July 19, 2016were generously provided by Dr. Mark Mayford (Line tTA-EC) (Yasuda and
Mayford, 2006) (available from MMRRC as stock #31779). The line was
backcrossed to C57BL/6 for at least four generations before being mated
with TRE-GlyCl for these studies.
CaMKIIa-tTA
CaMKIIa-TTA line B mice expressing the tetracycline transactivator (TTA)
under control of the calcium-calmodulin kinase type IIa (CaMKIIa) promoter
(Jackson Laboratories #3010) (Mayford et al., 1996) were used to create bi-
genic CaMKII-GlyCl offspring. This line had been backcrossed to C57BL/6J
for >20 generations prior to use in GlyCl matings for this study.
Drugs
For all in vivo experiments, Ivomec (1% ivermectin injectable solution, Merial)
was diluted to 0.2%with vehicle (3:2 mix of propylene glycol and 0.9% saline).
Stock dilutions were made fresh on the day of injection and administered
at 5 mg/kg intraperitoneally (i.p.). For in vitro electrophysiology studies,
Ivermectin powder (Sigma-Aldrich I8898) was dissolved in DMSO at a stock
concentration of 100 mM, stored at 20C for up to 1 week and diluted daily
to 100 nM with ACSF for the final working solution.
Brain Slice Electrophysiology
Whole-cell voltage-clamp recordings of layer 2 entorhinal neurons were
performed in acute brain slices to measure the number of action potentials
generated in response to 500 ms current injections (60 pA to 200 pA at
20 pA increments). Throughout the experiment, access resistance was
10–35MU and cells were discarded if Ra drifted above 20%. Current-response
relationships were constructed by counting the number of action potentials
generated at each current step in the presence or absence of IVM.
In separate set of experiments, field excitatory postsynaptic potential
(fEPSP) responses were recorded in the medial molecular layer of the dentate
gyrus following perforant path stimulation. Stimulus-response relationships
were calculated by plotting initial slope of the fEPSPs against stimulus inten-
sity, first in normal ACSF, then following addition of 100 nM IVM.
IVM Pharmacokinetics
Twelve-week-old adult ICR mice were injected with IVM and killed by
pentobarbital overdose between 3 hr to 4 days later. At each time point, four
mice (two males [M], two females [F]) were used for cardiac puncture and
brain dissection. Blood was collected into heparinized tubes and spun at
3,000 rpm for 15 min at 4C to isolate the plasma which was then snap frozen.
Brain tissue was extracted without perfusion, dissected along the midline, and
frozen on dry ice. The IVM concentrations in plasma and brain samples were
quantitated using validated liquid chromatography-tandem mass spectrom-
etry methods.
In Vivo Multi-tetrode Recordings
A craniotomy wasmade at2.0mmposterior and 1.5 mm lateral from bregma
to insert the drive cannula and position the tetrodes just above the cortex. An-
imals were given a week to recover before being placed on food restriction to
maintain 85% of their projected ad libitum body weight. Animals were trained
for3weeks to run laps forward and back for a food reward along a2m long
rectangular track. During training, chronically implanted tetrodes were slowly
lowered into the pyramidal layer of dorsal CA1 using the appearance of ripples
in the local field potential to identify the correct placement. A tetrode placed in
the cortex was used as the reference electrode. A metal screw was implanted
in the skull over the cerebellum to serve as the ground.
Recording began when the animals could reliably run at least ten laps in
each direction andmultiple stable hippocampal CA1 neurons could be isolated
as single-units. Details of recording procedures and data analysis have been
described previously (Ji and Wilson, 2007; Cheng and Ji, 2013). Tetrode re-
cordings were acquired using a DigitaLynx system (Neuralynx). Extracellular
voltage signals from four channels in each tetrode were digitized at 32 kHz
and band-pass filtered between 600 Hz and 9 kHz. Spikes were counted
when the voltage signal from any of the channels surpassed a trigger threshold
of 50–70 mV. Broadband local field potentials of 0.1 Hz–1 kHz were sampled
at 2 kHz. Single neurons were manually isolated using xclust (Matthew
Wilson, MIT).
Place Field Analysis
Active putative pyramidal neurons with amean firing rate between 0.5 and 7Hz
during any one of the three recording sessions were used to calculate mean
firing rate. Thus, any cell that had a mean rate of 0.5 to 7 Hz during one session
was also included in the calculation of mean firing rate for the remaining ses-
sions. This ensured that our analysis captured cells that underwent significant
changes in firing rate following IVM injection. For the calculation of place
field length and peak firing rate, only cells with a peak rate >1 Hz, a mean
rate >0.5 Hz and field length >10 cm on every session for that day of recording
were included. Thus, field length and peak rate calculations were based on a
subset of the total cells used for analysis of mean firing rate. Tentative place
fields were defined from the peak(s) in the rate curve for each cell active on
a trajectory. A threshold of 10% peak firing rate was used as the cutoff for
place field boundaries. By this method, the field began from the first point at
which the rate curve crossed above 10% peak rate and ended where it later
crossed below 10%peak rate. The field lengthwas calculated as the linear dis-
tance between these boundaries. Neighboring fields separated by <4 cmwere
combined into a single field.
Place Field Categorization
A place cell was classified as stable if its (1) place field location did not shift,
reflected by a significant correlation between rate curves obtained during
baseline and 4 hr post injection (p < 0.05, Pearson’s r), and (2) peak firing
rate at 4 hr was between 0.5 and 2 times of peak rate during the baseline ses-
sion. A cell was classified as rate modulated if its (1) place field location did not
shift across sessions, and (2) peak firing rate at 4 hr was <0.5 or more than
2 times of peak rate during the baseline session. A cell was classified as glob-
ally remapped if it (1) displayed a place field during the baseline session that
disappeared at 4 hr, or (2) was silent during baseline and became active at
4 hr, or (3) shifted firing location between the baseline and 4-hr sessions.
Multi-unit Activity Analysis
Sharp wave amplitude was assessed for each tetrode during the baseline
recording session and again after IVM injection. Only tetrodes with amplitude
changes of <20% across sessions were used for analysis. Multi-unit activity
(MUA) spikes were counted in 10-ms bins for all periods of running during
each track session. The MUA rate was defined as the total number of spikes
divided by the total time spent running. The MUA rate measured during the
baseline recording session was used to normalize rates measured during
the post injection sessions on each day.
Behavioral Assays
Mice aged to 3 months were handled for 3 days prior to the start of behav-
ioral testing, which began with an open field test to assess locomotor activ-
ity, followed by MWM to assess spatial reference memory, ending with cued
water maze testing to confirm visual acuity. Trials were recorded and tracked
using ANY-maze Video Tracking System. Prior to the start of Morris water
maze training, mice received 1 day of training in a straight swim channel
to acclimate them to the water and check for motor deficits. Acquisition
and refresher training in the MWM consisted of 4 trials/day with a 15 min
ITI followed by a 45 s short-term memory probe without the platform. Mice
were retired from training once they met two performance criteria during
the probe trial: first, R40% of their total swim path had to be located in
the trained quadrant, and second, their platform crossings over the trained
location had to be at least two times more than each of the three other equiv-
alent sites (NW, SW, SE) within the pool. Mice that did not reach criteria after
10 days of training were eliminated from further testing (n = 1 Nop and 3
Nop-GlyCl animals). Visual acuity testing was performed with a submerged
platform marked with a high-contrast striped pole that was initially placed
in the same quadrant as during training (NE) and then moved in pseudo-
random order to a new site so that all four intermediate cardinal points
were tested.
Statistics
Statistic comparisons used are described within the results; full details for
main statistical comparisons are shown in Table S2. Prism 6.0 software
(GraphPad) was used for all statistical analyses, with the exception of three-
way ANOVA which used R software (version 3.2.4). Statistical analyses were
designed to compare treatment within genotype, unless otherwise specified.
Wherever possible, data that was normally distributed was plotted using
mean ± SEM. In the case of non-normal distributions, data have been plotted
using median ± interquartile ranges as appropriate for non-parametric data-
sets. Significance values indicated in figures are for post hoc comparisons
and use standard nomenclature: *p < 0.05, **p < 0.01, ***p < 0.001, and
****p < 0.0001.SUPPLEMENTAL INFORMATION
Supplemental Information includes Supplemental Experimental Procedures,
seven figures, four tables, and onemovie and can be found with this article on-
line at http://dx.doi.org/10.1016/j.celrep.2016.06.032.
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